Vanguard Global Advisers
ICU icon

Vanguard Global Advisers’s SeaStar Medical ICU Stock Holding History

Vanguard Global Advisers’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606 Hold
165
– – ﹤0.01% 3629
2026
Q1 		$614 Buy
+165
New +$417 ﹤0.01% 3655

Other funds holding ICU

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Global Advisers's ICU Position: Q2 2026 in Review

Vanguard Global Advisers held its SeaStar Medical (ICU) position steady in Q2 2026 at 165 shares worth $606. The position accounts for ﹤0.01% of the portfolio, ranked #3629.

Vanguard Global Advisers first reported a position in ICU in Q1 2026 and has held it in 2 quarters since. The position peaked at $614 in Q1 2026. 19 funds tracked by Wall St. Rank hold ICU as of Q2 2026.

  • Vanguard Global Advisers held 165 shares of SeaStar Medical worth $606 as of Q2 2026.
  • Vanguard Global Advisers left its SeaStar Medical share count unchanged in Q2 2026.
  • SeaStar Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3629 holding.
  • Vanguard Global Advisers first reported a position in SeaStar Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's SeaStar Medical position peaked at $614 in Q1 2026.
  • 19 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.